Distribution Controller
Job description:
We are at the centre of the rapidly growing cell and gene therapy sector. We deliver life-changing therapies to patients, and so can you.
We are currently recruiting for a Distribution Controller to join the Warehouse and Supply Chain (WSC) team. The purpose of this role is to assist with the co-ordination and distribution of materials for Warehouse and Supply Chain. This includes all shipments and transportation inter site, customer, CMO and offsite storage of cold chain materials.
Our Warehouse and Supply Chain (WCS) team is critical to our Manufacturing success. They make sure we have the consumables and reagents needed to make our customers products, which then go on to change the lives of millions of patients. This multi-functional team works together to support all our logistics needs.
Your responsibilities in this role would be:
- Picking and packing of all shipments and material movements to and from internal/eternal customers /CMO’s for Supply Chain
- Completing documentation to meet customs requirements, packing specifications, and compliance
- Updating clinical trial inventory in IFS system
- Liaising with third parties in accordance with customer requirements
- With the use of a Company vehicle, transporting OXB materials to customers, Contract Manufacturing Organisations (CMO’s) and offsite storage
- Acting as back up to the Logistics Coordinator
- Maintaining inventory of all critical shipping materials
We are looking for:
Requirements:
- Clean UK Driving License
Preferred:
- Experienced in distribution activities
- Working knowledge of ERP Systems
- Knowledge of inventory management, distribution and transportation
- Demonstrate experience in a supply chain role in GMP environment
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation.These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you:
- Highly competitive total reward packages
- Wellbeing programmes
- Development opportunities
- Welcoming, friendly, supportive colleagues
- A diverse and inclusive working environment
- Our values are: Responsible, Responsive, Resilient, Respect
- State of the art laboratory and manufacturing facilities
We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.
Collaborate. Contribute. Change lives
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells.This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors.Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.